New from NPG

Special Web Collection: Diabetes and Hypertension

The treatment of diabetes and hypertension has become one of the greatest challenges for medical professionals today. It is estimated that by 2025 some 1.56 billion people will have hypertension and by 2030 around 366 million will have diabetes. FREE! From October 22nd 2007, Nature Clinical Practice will be presenting a selection of articles from a variety of Nature Publishing Group journals that will focus on these conditions.

Diabetes and hypertension: inextricably linked

naturejobs

natureproducts

NPG Journals in endocrinology Featured Articles
Nature Clinical Practice Endocrinology & Metabolism The role of thyroid autoimmunity in fertility and pregnancy
Nature Clinical Practice Endocrinology & Metabolism Treatment of male infertility secondary to morbid obesity
Journal of Human Hypertension Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives
American Journal of Hypertension Molecule-specific Effects of Angiotensin II–Receptor Blockers Independent of the Renin–Angiotensin System
British Journal of Cancer Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
British Journal of Pharmacology Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding
International Journal of Obesity Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects
Nature Clinical Practice Cardiovascular Medicine Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population
Clinical Pharmacology & Therapeutics Pharmacodynamics and Pharmacokinetics of the Novel Thrombopoietin Mimetic Peptide RWJ-800088 in Humans
Kidney International Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation
Obesity Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals
The Pharmacogenomics Journal Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or ?-blocker use and the risk of myocardial infarction and stroke
Modern Pathology Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas
Molecular Therapy Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy
Journal of Perinatology Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic and neural cell adhesion molecule in pregnancies with small for gestational age fetuses
Nature Medicine The long reach of leptin
Nature Reviews Drug Discovery Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Molecular Psychiatry Interferon-Α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior
Neuropsychopharmacology Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Food Intake in Mice Through Activation of the Hypothalamic Melanocortin System

NPG Gateways in endocrinology

ADVERTISEMENT